REFERENCES
- Gavin, M.C. , and Goa, K.L. , 2000. CNS Drugs. 16 (2000), pp. 779–786.
- Burris, K.D. , and Moiski, T.F. , 2002. J. Pharmacol. Exp. Ther. 302 (2002), pp. 381–389.
- Goodnuck, P.J. , and Jerry, J.M. , 2002. Expert Opinion on Pharmacotherapy 12 (2002), pp. 1773–1781.
- Chung, T.W. , Huang, Y.Y. , and Liu, Y.Z. , 2001. Int. J. Pharm. 212 (2001), pp. 161–169.
- Bodmeier, R. , and McGinity, J.W. , 1988. Int. J. Pharm. 43 (1988), pp. 179–186.
- Ciftei, K. , Kas, H.S. , Hincal, A.A. , Ercan, T.M. , Griven, O. , and Ruacan, S. , 1996. Int. J. Pharm. 131 (1996), pp. 73–82.
- Pavanetto, F. , Conti, B. , Genta, I. , and Giunchedi, P. , 1992. Int. J. Pharm. 2 (1992), pp. 151–159.
- Kassas, R.S. , Gilligan, C.A. , and Wanlu, A.L. , 1993. Int. J. Pharm. 94 (1993), pp. 59–67.
- Li, X. , Deng, X. , Yuan, M. , Xiong, C. , Huang, Z. , Zhang, Y. , and Jia, W. , 1999. Int. J. Pharm. 178 (1999), pp. 245–255.
- Tuncay, M. , Cali, S. , Ka, H.S. , Ercan, M.T. , and Peksoy, L. Hincal, A.A. , , 2000. Int. J. Pharm. 195 (2000), pp. 179–188.
- Guyoy, M. , and Fawaz, F. , 1998. Int. J.Pharm. 175 (1998), pp. 61–74.
- Kook, C.K. , Jung, K.M. , and Hee, O.K. , 1994. Int. J. Pharm. 106 (1994), pp. 213–219.
- Ansdrap, P.S. , and Moes, A.S. , 1993. Int. J. Pharm. 98 (1993), pp. 157–164.
- Liggins, R.T. , and Burt, H.M. , 2004. Int. J. Pharm. 281 (2004), pp. 103–106.
- Kilicarslan, M. , and Baykara, T. , 2003. Int. J. Pharm. 252 (2003), pp. 99–109.